Last reviewed · How we verify
NCT05485454
A Preference Study of Two Pneumatic Compression Devices for Patients With Lower Limb Lymphedema
NA trial testing Aria Health Aria Free in Lymphedema of Leg in 20 participants. Completed in 30 July 2022.
30 July 2022
Quick facts
| Lead sponsor | ResMed |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 11 June 2022 |
| Primary completion | 30 July 2022 |
| Estimated completion | 30 July 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Aria Health Aria Free
- A Traditional PCD
Conditions studied
- Lymphedema of Leg — all drugs for Lymphedema of Leg →
- Lymphedema — all drugs for Lymphedema →
- Lymphedema, Secondary — all drugs for Lymphedema, Secondary →
- Lymphedema Primary — all drugs for Lymphedema Primary →
Sponsor
ResMed — full company profile →
Who can join
18 and older, any sex, with Lymphedema of Leg or Lymphedema. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will aim to undertake a preference evaluation comparing the Aria Health Aria Free™ to a competitor's device by assessing overall satisfaction and preference of the devices individually and in comparison to one another. Twenty (20) subjects will be enrolled on this study at one study site in Houston, Texas.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05485454
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lymphedema of Leg
Currently open trials in the same condition.
- NCT06082349 — The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema · NA · recruiting
Other ResMed trials
Trials by the same sponsor.
- NCT07400861 — Study of Min-Max APAP Recommender Tool · NA · not yet recruiting
- NCT07099183 — Nyx3 Data Collection Study · not yet recruiting
- NCT06930404 — Data Collection Study to Review Novel Methods for Diagnosing Obstructive Sleep Apnea · not yet recruiting
- NCT05255744 — Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol · NA · unknown
- NCT03924817 — Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstru · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05485454 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ResMed
- Last refreshed: 15 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05485454.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing